{
     "PMID": "26477583",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160819",
     "LR": "20170220",
     "IS": "2045-2322 (Electronic) 2045-2322 (Linking)",
     "VI": "5",
     "DP": "2015 Oct 19",
     "TI": "Bv8/prokineticin 2 is involved in Abeta-induced neurotoxicity.",
     "PG": "15301",
     "LID": "10.1038/srep15301 [doi]",
     "AB": "Bv8/Prokineticin 2 (PROK2) is a bioactive peptide initially discovered as a regulator of gastrointestinal motility. Among multiple biological roles demonstrated for PROK2, it was recently established that PROK2 is an insult-inducible endangering mediator for cerebral damage. Aim of the present study was to evaluate the PROK2 and its receptors' potential involvement in amyloid beta (Abeta) neurotoxicity, a hallmark of Alzheimer's disease (AD) and various forms of traumatic brain injury (TBI). Analyzing primary cortical cultures (CNs) and cortex and hippocampus from Abeta treated rats, we found that PROK2 and its receptors PKR1 and PKR2 mRNA are up-regulated by Abeta, suggesting their potential involvement in AD. Hence we evaluated if impairing the prokineticin system activation might have protective effect against neuronal death induced by Abeta. We found that a PKR antagonist concentration-dependently protects CNs against Abeta(1-42)-induced neurotoxicity, by reducing the Abeta-induced PROK2 neuronal up-regulation. Moreover, the antagonist completely rescued LTP impairment in hippocampal slices from 6 month-old Tg2576 AD mice without affecting basal synaptic transmission and paired pulse-facilitation paradigms. These results indicate that PROK2 plays a role in cerebral amyloidosis and that PROK2 antagonists may represent a new approach for ameliorating the defining pathology of AD.",
     "FAU": [
          "Severini, Cinzia",
          "Lattanzi, Roberta",
          "Maftei, Daniela",
          "Marconi, Veronica",
          "Ciotti, Maria Teresa",
          "Petrocchi Passeri, Pamela",
          "Florenzano, Fulvio",
          "Del Duca, Ester",
          "Caioli, Silvia",
          "Zona, Cristina",
          "Balboni, Gianfranco",
          "Salvadori, Severo",
          "Nistico, Robert",
          "Negri, Lucia"
     ],
     "AU": [
          "Severini C",
          "Lattanzi R",
          "Maftei D",
          "Marconi V",
          "Ciotti MT",
          "Petrocchi Passeri P",
          "Florenzano F",
          "Del Duca E",
          "Caioli S",
          "Zona C",
          "Balboni G",
          "Salvadori S",
          "Nistico R",
          "Negri L"
     ],
     "AD": "Institute of Cell Biology and Neurobiology, CNR, Via del Fosso di Fiorano, 64, 00143, Roma. European Brain Research Institute, Via del Fosso di Fiorano, 64, 00143 Rome. Department of Human Physiology and Pharmacology \"Vittorio Erspamer\", University of Roma \"La Sapienza\", P.za A. Moro 5, 00185 Roma. Department of Human Physiology and Pharmacology \"Vittorio Erspamer\", University of Roma \"La Sapienza\", P.za A. Moro 5, 00185 Roma. Department of Human Physiology and Pharmacology \"Vittorio Erspamer\", University of Roma \"La Sapienza\", P.za A. Moro 5, 00185 Roma. Institute of Cell Biology and Neurobiology, CNR, Via del Fosso di Fiorano, 64, 00143, Roma. Institute of Cell Biology and Neurobiology, CNR, Via del Fosso di Fiorano, 64, 00143, Roma. European Brain Research Institute, Via del Fosso di Fiorano, 64, 00143 Rome. European Brain Research Institute, Via del Fosso di Fiorano, 64, 00143 Rome. University of Rome \"Tor Vergata\" 00133 Rome. IRCCS Fondazione Santa Lucia, Via Ardeatina, 306, 00142 Roma. University of Rome \"Tor Vergata\" 00133 Rome. IRCCS Fondazione Santa Lucia, Via Ardeatina, 306, 00142 Roma. Department of Life and Environmental Sciences, University of Cagliari, Via Ospedale, 72, 09124 Cagliari. Department of Pharmaceutical Sciences, Universita of Ferrara, Ferrara. European Brain Research Institute, Via del Fosso di Fiorano, 64, 00143 Rome. University of Rome \"Tor Vergata\" 00133 Rome. Department of Human Physiology and Pharmacology \"Vittorio Erspamer\", University of Roma \"La Sapienza\", P.za A. Moro 5, 00185 Roma.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151019",
     "PL": "England",
     "TA": "Sci Rep",
     "JT": "Scientific reports",
     "JID": "101563288",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Gastrointestinal Hormones)",
          "0 (Neuropeptides)",
          "0 (Peptide Fragments)",
          "0 (Prok2 protein, rat)",
          "0 (Receptors, G-Protein-Coupled)",
          "0 (amyloid beta-protein (1-42))"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/genetics/metabolism",
          "Amyloid beta-Peptides/*metabolism/toxicity",
          "Animals",
          "Apoptosis/drug effects",
          "Gastrointestinal Hormones/genetics/*metabolism",
          "Gene Expression Regulation/drug effects",
          "Hippocampus/metabolism",
          "Long-Term Potentiation/drug effects/genetics",
          "Male",
          "Mice",
          "Mice, Transgenic",
          "Neurons/drug effects/*metabolism",
          "Neuropeptides/genetics/*metabolism",
          "Peptide Fragments/metabolism/toxicity",
          "Protein Transport",
          "Rats",
          "Receptors, G-Protein-Coupled/antagonists & inhibitors/genetics/metabolism",
          "Up-Regulation"
     ],
     "PMC": "PMC4610025",
     "EDAT": "2015/10/20 06:00",
     "MHDA": "2016/08/20 06:00",
     "CRDT": [
          "2015/10/20 06:00"
     ],
     "PHST": [
          "2015/02/02 00:00 [received]",
          "2015/08/26 00:00 [accepted]",
          "2015/10/20 06:00 [entrez]",
          "2015/10/20 06:00 [pubmed]",
          "2016/08/20 06:00 [medline]"
     ],
     "AID": [
          "srep15301 [pii]",
          "10.1038/srep15301 [doi]"
     ],
     "PST": "epublish",
     "SO": "Sci Rep. 2015 Oct 19;5:15301. doi: 10.1038/srep15301.",
     "term": "hippocampus"
}